St. Louis Children’s Hospital

FONT SIZEDecrease font-size Restore default font-sizes Increase font-size
Bookmark and Share
Protocols


Transplant Protocols

  • 01-0923 A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Non- Myloablative Preparatory Regime with Campath-1H, Fludarabine and Melphalan
  • CTN 0201 A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors
  • CTN 0501 Double vs. Single Umbilical Cord Blood Transplants
  • CTN 0601 Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
  • AAML0531 A Phase III Randomized Trial of Gemtuzumab Ozogamicin Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescences, and Young Adults
  • AAML05P1 Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Cell Transplantation (HCT) for Refractory and Relapsed Acute Myelogenous Leukemia (AML) and Newly Diagnosed AML with Monosomy 7 or -5/5q- in Children: A Children’s Oncology Group (COG) Study
  • Head Start III  A Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternate Intesive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide and Autologus Stem Cell Rescue
  • ACNS0333 Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation 
  • ACNS0334 A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate
  • AEWS0031 European Ewing Tumor Working Initiative of National Groups Ewing Tumor Studies 1999 (EURO-E.W.I.N.G.99)
  • ANBL0532 Phase III Randomized Trial of Single vs. Tandem Myeloablative as Consolidation Therapy for High-Risk Neuroblastoma
  • ASCT0431 A Randomized Trial of Sirolimus-Based Graft versus Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Relapsed Acute Lymphoblastic Leukemia (ALL)

Standard Treatment

  • Autologous
    • Total Body Irradiation/Etoposide/Cytoxan
    • Fractionated Total Body Irradiation/Cytoxan
    • Carmustine/Etoposide/Ara-C/Cytoxan
    • Carmustine/Ara-C/Etoposide/Melphalan
    • Busulfan/Cytoxan
    • Melphalan/Etoposide/Carboplatinum
    • Melphalan (1)
    • Melphalan (2)
    • Etoposide/Thiotepa/Cytoxan
  • Allogeneic
    • Total Body Irradiation/Etoposide/Cytoxan
    • Busulfan/Cytoxan
    • High Dose Cytoxan
    • Fractionated Total Body Irradiation/Cytoxan
    • Single Dose Total Body Irradiation
    • Fludarabine/Busulfan
    • Fludarabine/Cytoxan
    • Fludarabine/Melphalan
    • Fludarabine/Melphalan/ATG (1)
    • Fludarabine/Melphalan/ATG (2)
    • Cytoxan/ATG

Additional Protocols

  • 01-1014 Tissue Acquisition for Analysis of Genetic Progression Factors in Hematologic Malignancies
  • 03-0363 Hearing Loss in Pediatric Cancer Patients: Assessment of Risk Factors
  • 06-0097 Documenting Speech and Language Impairment in Pediatric Oncology Patients with Sensorineural Loss
  • ANBL0032 Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
  • ASCT0521 Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation.
  • ASCT0631 A Phase III Randomized Trial of G-CSF Stimulated Bone Marrow vs. Conventional Bone Marrow as a Stem Cell Source in Matched Sibling Donor Transplantation

Future Protocols

  • PBMTC NMD091  A Pilot Trial of Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Thalassemia Using a Reduced Intensity Conditioning Regimen (URTH Trial)

St. Louis Children's Hospital is affiliated with Washington University School of Medicine.

COPYRIGHT © 2009, ST. LOUIS CHILDREN'S HOSPITAL, ALL RIGHTS RESERVED

Directions | Contact Us | Site Map | Employment | Media | HIPAA | Terms of Use / Privacy

St. Louis Children's Hospital • One Children's Place • St. Louis, MO • 63110 • 314.454.6000